Development
Acrivon Therapeutics, Inc.
ACRV
$1.35
$0.108.00%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 84.96% | 80.01% | 20.69% | 28.26% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 29.91% | -29.48% | -- | 439.63% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 83.66% | 75.86% | -- | 31.56% | -- |
|
|
|||||
| Total Current Assets | 83.66% | 75.86% | -- | 31.56% | -- |
| Net Property, Plant & Equipment | -12.94% | -11.95% | -- | 18.49% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -78.73% | -33.33% | -- | 0.00% | -- |
| Total Assets | 72.26% | 68.48% | -- | 70.03% | -- |
|
|
|||||
| Total Accounts Payable | -23.89% | -33.39% | -- | -6.22% | -- |
| Total Accrued Expenses | 162.49% | 170.99% | -- | 239.67% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 8.23% | 6.66% | -- | 9.34% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 1,024.24% | -- |
| Total Other Current Liabilities | -- | -- | -- | 1,024.24% | -- |
| Total Current Liabilities | 45.50% | 57.61% | -- | 123.61% | -- |
|
|
|||||
| Total Current Liabilities | 45.50% | 57.61% | -- | 123.61% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.56% | -16.38% | -- | -14.69% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 19.72% | 20.00% | -- | 36.47% | -- |
|
|
|||||
| Common Stock & APIC | 14,444.38% | 17,380.29% | -- | 21,358.52% | -- |
| Retained Earnings | -106.29% | -118.18% | -- | -125.34% | -- |
| Treasury Stock & Other | -127.07% | -- | -- | -- | -- |
| Total Common Equity | 402.85% | 507.87% | 773.98% | 816.01% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 402.85% | 507.87% | 773.98% | 816.01% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 79.64% | 73.59% | 62.57% | 72.70% | -- |
|
|
|||||